FIG 2.
Median survival times (A), survival curves (B), fungal burdens (C), and total inflammation scores (D) of mice treated with increasing doses of ruxolitinib or placebo started 1 day before (D−1) or after (D+1) infection.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.